Catalyst

Slingshot members are tracking this event:

Discovery Labs (DSCO) to Release Top-Line Phase 2a Results on Aerosolized KL4 Surfactant in Treatment of RDS on November 12, 2015 Investor Conference Call

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
DSCO

100%

Additional Information

Clinical Data AEROSURF treated patients experienced a 20% absolute reduction or a 38% relative reduction in nCPAP failure compared to control
http://discoverylabs...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 12, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2, Aerosurf, Infants With Respiratory D